Axsome Therapeutics Inc at Needham Neuroscience Forum (Virtual) Transcript
Good morning, everyone, again. Welcome to the next session with Axsome. I am Ami Fadia, the analyst at Needham that covers neuroscience and targeted oncology. I have the pleasure of hosting Herriot Tabuteau, Founder, CEO and Chairman of the Board at Axsome.
Herriot, we've got a lot of things to talk about, a lot of things happening at the company. But perhaps if you could give us a quick 30 second overview and then we'll jump right into questions. And just for the audience, if you would like me to ask any questions, feel free to send over to me via the chat. With that, Herriot?
Thank you, Ami, for having us at your -- I think this is the first annual neuroscience forum at Needham. So, we're honored to participate. With regards to Axsome and a broad overview, so we are a CNS focused company. We have a very deep pipeline, which is late stage.
And this is a very interesting time in the company's history for the company in terms of all the work that we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
